HABA Laboratories,Inc.
(株)ハーバー研究所
2026/11/13 19:59 Updated
Market Cap:
$39.3M (¥6.3B)
Stock Price:
$10.39 (¥1,660)
Exchange Rate: 1 USD = ¥159.74
Stock Price Chart
2026/11/13 19:59 Updated9.22
PER (Price Earnings Ratio)
vs Industry Avg: -0.3
0.67
PBR (Price to Book Ratio)
vs Industry Avg: -0.6
2.40%
Dividend Yield
vs Industry Avg: -0.55%
Price Trend
2026/11/13 19:59 UpdatedShort-term
5-Day MA
-
Near-term
25-Day MA
-0.72%
Mid-term
75-Day MA
-2.96%
Long-term
200-Day MA
-3.32%
Price & Trading Details
2026/11/13 19:59 UpdatedPRICE
Previous Close
¥1,665
Open
¥1,668
High
¥1,668
Low
¥1,658
Close
¥1,660
TRADING
Volume
900
Average Volume
1,945
Turnover
¥1,494,000
Min. Purchase
¥166,000
Shareholder Composition
Updated 2026/11/0140.5%
Insider Holdings
0.6%
Institutional
59.0%
Public Float
4
Institutional Holders
Insider Holdings
40.5%
Institutional
0.6%
Public Float
59.0%
Dividend History
Updated 2026/11/08
-%
Dividend Yield
¥40
Annual Dividend
0.0%
YoY Growth
19.9%
Payout Ratio
| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥40 | 0.0% |
| 2025 | ¥40 | 0.0% |
| 2024 | ¥40 | 0.0% |
| 2023 | ¥40 | 0.0% |
| 2022 | ¥40 | - |
Financial Performance
2026/11/08 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥12,038M | ¥12,324M | ¥12,062M | ¥12,141M |
| Gross Profit | ¥8,169M | ¥8,404M | ¥8,093M | ¥8,087M |
| Operating Income | -¥610M | -¥188M | ¥590M | ¥727M |
| Pretax Income | -¥543M | -¥1,834M | ¥653M | ¥867M |
| Net Income | -¥708M | -¥2,119M | ¥577M | ¥760M |
| EPS | -¥187.19 | -¥560.26 | ¥152.47 | ¥201.07 |
| Operating Margin | -5.06% | -1.52% | 4.89% | 5.99% |
| Balance Sheet | ||||
| Total Assets | ¥14,655M | ¥12,431M | ¥12,344M | ¥12,519M |
| Total Equity | ¥10,774M | ¥8,507M | ¥8,927M | ¥9,536M |
| Total Liabilities | ¥3,882M | ¥3,924M | ¥3,417M | ¥2,983M |
| Cash | ¥4,818M | ¥3,959M | ¥4,744M | ¥5,785M |
| Interest-bearing Debt | ¥2,033M | ¥2,355M | ¥1,817M | ¥1,188M |
| Equity Ratio | 73.51% | 68.43% | 72.32% | 76.17% |
| D/E Ratio | 0.19 | 0.28 | 0.20 | 0.12 |
| Cash Flow | ||||
| Operating CF | ¥56M | -¥588M | ¥1,621M | ¥1,237M |
| Investing CF | -¥214M | -¥442M | -¥147M | ¥485M |
| Financing CF | -¥676M | ¥171M | -¥689M | -¥781M |
| Free CF | -¥233M | -¥1,021M | ¥1,409M | ¥1,128M |
| Efficiency | ||||
| ROE | -6.57% | -24.90% | 6.46% | 7.97% |
| ROA | -4.83% | -17.04% | 4.67% | 6.07% |
Latest News (5 items)
Company Information
English Name
HABA Laboratories,Inc.
Japanese Name
(株)ハーバー研究所
Stock Code
4925.T (JPX)
Sector / Industry
Consumer Defensive / Household & Personal Products
Website
https://www.haba.com
Employees
523
About
HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. The company's skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products, such as shampoos, conditioners, hair treatment, body shampoo, hand care, and hand and body soaps products. It also offers petroleum-based surfactants, synthetic fragrances, mineral oil, and tar-based dyes. It sells its products through online shopping, shop sales, and drug/variety stores. The company has shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was incorporated in 1976 and is headquartered in Chiyoda, Japan.
Data provided by Yahoo Finance
